Patten & Patten’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-14,716
Closed -$1.36M 242
2019
Q2
$1.36M Sell
14,716
-6,374
-30% -$605K 0.15% 114
2019
Q1
$1.99M Sell
21,090
-1,025
-5% -$89.6K 0.22% 89
2018
Q4
$1.42M Sell
22,115
-32,175
-59% -$2.38M 0.17% 98
2018
Q3
$4.86M Buy
54,290
+4,652
+9% +$411K 0.48% 59
2018
Q2
$3.94M Sell
49,638
-4,894
-9% -$406K 0.4% 65
2018
Q1
$4.87M Buy
54,532
+5,776
+12% +$554K 0.5% 60
2017
Q4
$5.09M Buy
48,756
+8,309
+21% +$938K 0.51% 61
2017
Q3
$5.9M Sell
40,447
-1,770
-4% -$241K 0.62% 54
2017
Q2
$5.48M Sell
42,217
-1,115
-3% -$137K 0.61% 55
2017
Q1
$5.39M Buy
43,332
+157
+0.4% +$18.8K 0.62% 54
2016
Q4
$5M Sell
43,175
-14,374
-25% -$1.6M 0.61% 56
2016
Q3
$6.02M Sell
57,549
-1,040
-2% -$113K 0.78% 42
2016
Q2
$5.78M Buy
58,589
+869
+2% +$89.9K 0.8% 44
2016
Q1
$5.78M Buy
57,720
+6,150
+12% +$633K 0.83% 41
2015
Q4
$6.18M Buy
51,570
+3,401
+7% +$393K 0.85% 42
2015
Q3
$5.21M Buy
48,169
+13,480
+39% +$1.67M 0.8% 49
2015
Q2
$4.01M Buy
34,689
+1,080
+3% +$123K 0.58% 60
2015
Q1
$3.87M Buy
33,609
+2,009
+6% +$240K 0.56% 61
2014
Q4
$3.54M Buy
31,600
+7,605
+32% +$802K 0.53% 63
2014
Q3
$2.27M Buy
+23,995
New +$2.17M 0.36% 76

Other funds holding CELG

Patten & Patten's CELG Position: Q3 2019 in Review

Patten & Patten sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 14,716 shares — an estimated $1.36M sold.

Patten & Patten first reported a position in CELG in Q3 2014 and held it in 20 quarters. The position peaked at $6.18M in Q4 2015. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Patten & Patten reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Patten & Patten sold 14,716 Celgene Corp shares in Q3 2019, an estimated $1.36M.
  • Patten & Patten first reported a position in Celgene Corp in Q3 2014 and held it in 20 quarters.
  • Patten & Patten's Celgene Corp position peaked at $6.18M in Q4 2015.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Patten & Patten's 13F filing for Q3 2019, filed 15 Oct 2019.